Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens

Sponsor
Susanne Arnold (Other)
Overall Status
Completed
CT.gov ID
NCT01648166
Collaborator
United States Department of Defense (U.S. Fed)
520
1
96.1
5.4

Study Details

Study Description

Brief Summary

This is a research study about the relationship between lung cancer and environmental risk factors. The purpose of this study is to try to understand the effects of trace elements such as arsenic and chromium, as well as radon on the development of lung cancer. To do this, the investigators will collect information and environmental and biologic specimens from people who live in Appalachian Kentucky who a) have lung cancer or b) don't have lung cancer and will serve as control subjects. The investigators will create a specimen repository of from these people and their residences to compare differences in many risks factors for cancer. By doing this study, the investigators hope to learn why there are more lung cancers in Kentucky's fifth Congressional District than anywhere else in the nation.

Condition or Disease Intervention/Treatment Phase
  • Other: Environmental sampling

Detailed Description

Appalachian Kentucky has one of the highest incidence rates of lung cancer in the United States. The disproportionately high incidence is not explained by tobacco alone. Preliminary analysis of trace element content in toenail samples reveals higher levels of arsenic, chromium and nickel in Appalachian Kentucky residents than elsewhere in Kentucky. Trace elements are known to promote carcinogenesis by increased oxidative stress, inflammation, DNA damage, and reduced DNA repair efficiency. These findings justify further investigation of the role that trace elements play in the development of lung cancer in this region. Hypothesis: The unexpectedly high rate of lung cancer in Appalachian Kentucky is associated with exposure to environmental carcinogens that increase oxidative stress and DNA damage.

Specific Aims Aim 1: Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls.

Aim 2: Create a specimen repository of biologic and environmental samples from these subjects and their residences for analysis of DNA repair markers and, in the future, markers of oxidative stress and inflammation.

Aim 3: Fund four pilot projects which will utilize collected data from Aim 1 to develop investigators focused on lung cancer research in this study population and to generate preliminary data that will lead to independent funding.

Study Design: This is a population-based, case-control study encompassing the 5th Congressional District of Kentucky.

Relevance: This translational research and repository will fundamentally improve our understanding of the causes of the disproportionately high incidence of lung cancer in Appalachian Kentucky, foster collaboration among scientists dedicated to the study of lung cancer and provide a permanent resource to be used for future research.

Study Design

Study Type:
Observational
Actual Enrollment :
520 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
A Population-based Case-control Study of Lung Cancer in Appalachian Kentucky: The Role of Environmental Carcinogens
Actual Study Start Date :
Sep 1, 2011
Actual Primary Completion Date :
Sep 1, 2014
Actual Study Completion Date :
Sep 4, 2019

Arms and Interventions

Arm Intervention/Treatment
lung cancer cases

subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky

Other: Environmental sampling
Soil, water, blood, urine, hair and radon testing in homes in Appalachia

control subjects

subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky

Other: Environmental sampling
Soil, water, blood, urine, hair and radon testing in homes in Appalachia

Outcome Measures

Primary Outcome Measures

  1. Rate of Moderate to High Arsenic Level in Cases and Controls [up to three years]

    Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls (primary endpoint).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes

The following eligibility criteria are required for study entry and participation.

Inclusion (Lung cancer cases):
  • Living persons with histologically or cytologically confirmed primary carcinoma of the lung (International Classification of Diseases-9, 162.2-162.9) between October 17, 2011 and October 16, 2013

  • Age greater than 17

  • Must be residents of the 5th Congressional District

  • No prior history of any cancer (other than stage I and II non-melanomatous skin cancer)

  • Must have a working phone

  • Ability to participate in an in-person interview

  • English speaking will be eligible for the study (no proxy respondents will be used)

Inclusion (Control cases):
  • Age greater than 17

  • No prior history of any cancer (other than stage I and II non-melanomatous skin cancer)

  • Must be residents of the 5th Congressional District at the time they are matched to the case.

  • Must have a working phone

  • Ability to participate in an in-person interview

  • English speaking will be eligible for the study (no proxy respondents will be used)

Exclusion:
  • History of any cancers other than those listed above

  • Non-residents of the 5th congressional district of Kentucky

  • Age 17 years or less

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Kentucky Lexington Kentucky United States 40536

Sponsors and Collaborators

  • Susanne Arnold
  • United States Department of Defense

Investigators

  • Principal Investigator: Susanne M Arnold, MD, Lucille P. Markey Cancer Center at University of Kentucky

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susanne Arnold, MD, University of Kentucky
ClinicalTrials.gov Identifier:
NCT01648166
Other Study ID Numbers:
  • DOD2011-193
First Posted:
Jul 24, 2012
Last Update Posted:
Nov 7, 2019
Last Verified:
Oct 1, 2019
Keywords provided by Susanne Arnold, MD, University of Kentucky
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Lung Cancer Cases Control Subjects
Arm/Group Description subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia
Period Title: Overall Study
STARTED 153 367
COMPLETED 100 267
NOT COMPLETED 53 100

Baseline Characteristics

Arm/Group Title Lung Cancer Cases Control Subjects Total
Arm/Group Description subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia Total of all reporting groups
Overall Participants 100 267 367
Age (years) [Median (Full Range) ]
Median (Full Range) [years]
62
62
62
Sex: Female, Male (Count of Participants)
Female
61
61%
148
55.4%
209
56.9%
Male
39
39%
119
44.6%
158
43.1%
Region of Enrollment (participants) [Number]
United States
100
100%
267
100%
367
100%

Outcome Measures

1. Primary Outcome
Title Rate of Moderate to High Arsenic Level in Cases and Controls
Description Conduct a case-control study of lung cancer and matched controls in the 5th Congressional District of Kentucky to compare rates of moderate to high arsenic in lung cancer cases and controls (primary endpoint).
Time Frame up to three years

Outcome Measure Data

Analysis Population Description
those with adequate toenail arsenic concentrations
Arm/Group Title Lung Cancer Cases Control Subjects
Arm/Group Description subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia
Measure Participants 100 267
Median (Inter-Quartile Range) [mcg/dL]
0.04
0.04

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Lung Cancer Cases Control Subjects
Arm/Group Description subjects with lung cancer who are greater than 17 years of age and live in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia subjects without lung cancer, greater than 17 who reside in Appalachian Kentucky Environmental sampling: Soil, water, blood, urine, hair and radon testing in homes in Appalachia
All Cause Mortality
Lung Cancer Cases Control Subjects
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Lung Cancer Cases Control Subjects
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/100 (0%) 0/267 (0%)
Other (Not Including Serious) Adverse Events
Lung Cancer Cases Control Subjects
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/100 (0%) 0/267 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Susanne Arnold
Organization University of Kentucky
Phone 8592579568
Email smarno0@uky.edu
Responsible Party:
Susanne Arnold, MD, University of Kentucky
ClinicalTrials.gov Identifier:
NCT01648166
Other Study ID Numbers:
  • DOD2011-193
First Posted:
Jul 24, 2012
Last Update Posted:
Nov 7, 2019
Last Verified:
Oct 1, 2019